title: Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity.
abstract: We report on a syndrome of spondylo-epimetaphyseal dysplasia, dentinogenesis imperfecta, and ligamentous hyperextensibility in two sibs born to nonconsanguineous parents. This chondrodysplasia was characterized by severe shortness of stature and an osteoporosis without fractures. Electron microscopic examination of the cartilage documented large vacuoles of dilated rough endoplasmic reticulum within the cytoplasm of chondrocytes. Gel electrophoresis of pepsin-soluble collagen extracted from cartilage demonstrated the presence of type II collagen chains with an abnormal mobility. Prolyl and lysyl hydroxylations were slightly increased. The abnormal molecules melted at a higher temperature than the normal ones. CNBr peptide mapping of type II collagen showed an altered electrophoretic migration of peptides CB 11, CB 8, and CB 10,5 whereas CB 9,7 looked normal. In addition, two small non-collagenous proteins isolated from cartilage were not found in an age-matched control individual but were detected in a normal newborn infant. The quantitation of proline-labelled collagen synthesized by dermal fibroblasts demonstrated a 50% reduction of total collagen. This decrease essentially affected the amount of extracellular type I collagen, which was secreted less efficiently than in control cells. Nevertheless, type I collagen chains behaved normally on 5% polyacrylamide gels. The reduced mRNA levels of alpha 1I and alpha 2I chains might reflect either a transcriptional defect or a decreased stability of mRNA transcripts. We suggest that the association of both pathological chondrocytes producing altered collagen type II and decreased synthesis of type I could be responsible for this peculiar phenotype. The overmodification of alpha 1II CNBr peptides is consistent with the presence of a single-base substitution in the COL2A1 gene. Whether there is a direct causal relationship between the type II collagen defect and the underexpression of type I collagen will require clarification.
authors: Clinique Maurice Lamy, Hôpital des Enfants Malades, Paris, France.
authors: J
authors: J
authors: Bonaventure
authors: R
authors: R
authors: Stanescu
authors: V
authors: V
authors: Stanescu
authors: J C
authors: JC
authors: Allain
authors: M P
authors: MP
authors: Muriel
authors: D
authors: D
authors: Ginisty
authors: P
authors: P
authors: Maroteaux
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics* / Q000378:metabolism; D002357:Cartilage Diseases / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D002648:Child; D003094:Collagen / Q000032:analysis / Q000172:deficiency* / Q000235:genetics; D003095:Collagen Diseases / Q000235:genetics* / Q000378:metabolism; D003811:Dentinogenesis Imperfecta / Q000235:genetics* / Q000378:metabolism; D004392:Dwarfism / Q000235:genetics / Q000378:metabolism; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006132:Growth Plate / Q000737:chemistry / Q000473:pathology; D006801:Humans; D007231:Infant, Newborn; D008022:Ligaments / Q000002:abnormalities*; D008297:Male; D011489:Protein Denaturation; D011509:Proteoglycans / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D013577:Syndrome
chemical_list: D011509:Proteoglycans; D012333:RNA, Messenger; D003094:Collagen